Zinc has been known for many years to inhibit apoptosis but the mechanism remains unclear. Originally thought to inhibit an apoptotic endonuclease, zinc has subsequently been shown to inhibit steps earlier in the pathway. Since many additional steps in apoptosis have now been defined, we have re-evaluated the steps inhibited by zinc. In response to activation of the chemical-mediated death pathway by anisomycin, 0.3 mM zinc inhibited Bax and Bak activation, cytochrome c release, and all of the subsequent steps in apoptosis. In the receptor-mediated death pathway initiated by Fas or tumor necrosis factor, 3 mM zinc was required to inhibit apoptosis as judged by inhibition of caspase 3 activity and DNA digestion, but it failed to inhibit cytochrome c release, activation of Bax and Bak, or upstream signaling events in this pathway. These results are consistent with zinc selectively inhibiting activation of BH3-only proteins required in the chemical pathway but inhibiting downstream caspase activation in the death-receptor pathway.
Introduction
Caspases play a critical role in the regulation of both the receptor-mediated and drug-induced apoptotic pathways. In the Fas receptor-mediated pathway, the Fas ligand leads to recruitment of caspase 8 to the receptor, where it is cleaved and activated. 1 Two death pathways can then occur. In one, caspase 8 directly cleaves downstream effector caspases such as caspase 3, leading to DNA digestion and proteolysis of the cell. 2 The second pathway is more indirect, requiring that caspase 8 cleave the proapoptotic Bcl-2 family member Bid.
3 Truncated Bid (tBid) then translocates to the mitochondria and causes cytochrome c release. 3, 4 Recent reports have shown that Bax or Bak, also proapoptotic members of the Bcl-2 family, are required for tBid to mediate this apoptotic cascade. 5, 6 Release of cytochrome c and/or Smac/Diablo culminates in the activation of downstream caspases and finally DNA digestion. [7] [8] [9] In chemical-induced apoptosis, the upstream effectors are not as clearly understood, but the signals also impact on the Bcl-2 family of proteins. The current model suggests that once the insult has been detected and the cell has made the decision to undergo apoptosis, Bax translocates from the cytosol to the mitochondria, where it oligomerizes. This activation of Bax occurs independently of Bid activation, 10 and may involve some other BH3-only member of the Bcl-2 family. Following Bax activation, cytochrome c is released and downstream caspases are activated. Another proapoptotic Bcl-2 family member, Bak, is constitutively present in mitochondria, but otherwise acts like Bax in that it oligomerizes in response to an apoptotic stimulus leading to cytochrome c release. In this chemical-mediated pathway, caspase 8 and Bid may also be activated, but as a consequence of feedback from caspase 3. 2, 10 This feedback indicates that caspase 8 and Bid do not play significant roles in chemical-induced apoptosis but are simply activated in response to other caspases after the critical step of cytochrome c release.
Zinc is an inhibitor of apoptosis. It was originally shown to inhibit glucocorticoid-induced killing of mouse thymocytes at a concentration of 400 mM. 11 Zinc concentrations of 200-5000 mM zinc have also been shown to inhibit p75NTR, TGFb, and Fas receptor-mediated apoptosis. [12] [13] [14] Additionally, zinc inhibits apoptosis induced through the chemical pathway by etoposide, staurosporine, and microtubule disrupting drugs. [15] [16] [17] [18] These levels of zinc are unlikely to be attained physiologically; rather they are an experimental means to elevate intracellular zinc. Protection can be afforded at much lower zinc concentrations when zinc ionophores are used. 19 In these cases, 25 mM zinc can be adequate to protect cells. The physiological relevance of zinc to the regulation of apoptosis has been further demonstrated by the observation that decreased intracellular zinc concentrations may precede early indicators of apoptosis in HL60 cells, 20 while zinc depletion in cells results in apoptosis. 21, 22 The mechanism by which zinc inhibits apoptosis is not clearly understood. It was originally thought to inhibit the endonuclease involved in apoptotic DNA digestion. 23 However, it was subsequently shown that this protection was more likely mediated at a step further upstream in the apoptotic pathway. This laboratory established that zinc inhibits apoptosis induced by both receptor-and chemical-mediated pathways and this appeared to occur upstream of the activation of caspase 3. 16 Reports also suggest that zinc increases protein kinase C activity, 24 which may result in the protection of cells from apoptosis. Recently, zinc has also been shown to inhibit the production of cyclic AMP by direct binding to adenylate cyclases, 25 providing another possible mechanism of cell protection. Since many additional steps in the apoptotic pathway have now been defined, we have reevaluated the step(s) inhibited by zinc.
In response to activation of the chemical-mediated death pathway, 0.3 mM zinc inhibited Bax and Bak oligomerization and all of the subsequent steps in apoptosis. In the receptormediated death pathway, 3 mM zinc was required to inhibit apoptosis as judged by inhibition of caspase 3 activity and DNA digestion, but it failed to inhibit Bax and Bak oligomerization and upstream signaling events in this pathway. These results demonstrate that zinc inhibits the two pathways at different steps and accordingly may help to identify critical regulators of apoptosis.
Results

Anisomycin-induced apoptosis is inhibited by low concentrations of zinc
Anisomycin is a potent activator of the chemical pathway of apoptosis. Incubation of human ML-1 leukemia cells with 10 mg/ml anisomycin for 2 h resulted in greater than 90% Hoechst positive staining, indicative of chromatin condensation, and extensive DNA digestion as measured by agarose gel electrophoresis (Figure 1 ). Anisomycin treatment alone resulted in DNA digestion as measured by agarose gel electrophoresis ( Figure 1 ). D4GDI cleavage, indicative of caspase 3 activation, also occurred in response to anisomycin. Bax translocated from the cytosolic to the pellet fraction of cells and cytochrome c was released from the mitochondria (i.e., the pellet fraction) into the cytosol (Figure 1b) . Caspase 8 cleavage also occurred in the cytosolic fraction of cells in response to anisomycin, and Bid was subsequently activated as observed by the appearance of a 14 kDa cleavage product in the pellet fraction and a decrease in the parent band in the cytosol fraction.
A range of concentrations of zinc were administered to ML-1 cells concurrently with anisomycin. Zinc at 0.1-0.3 mM inhibited Bax translocation and, as a result, all of the subsequent steps in apoptosis that were measured ( Figure  1 ). At 0.3 mM zinc, cytochrome c was retained in the pellet fraction and caspase 8 and Bid cleavage no longer occurred.
Parallel experiments were performed in Jurkat cells that express Bak but not Bax. All of the common steps in chemicalinduced apoptosis were activated by anisomycin (Figure 2 ). Zinc inhibited all the steps in Jurkat cells as it did in ML-1 cells, suggesting that the same upstream apoptotic signaling step was inhibited by zinc. Specifically, 0.3 mM zinc inhibited DNA digestion and cleavage of D4-GDI. Cytochrome c release into the cytosol, caspase 8 cleavage, and Bid activation were also inhibited at this concentration, as seen in ML-1 cells.
Zinc inhibits Bax and Bak oligomerization that normally occur during anisomycin-mediated apoptosis
We next measured the ability of zinc to inhibit Bax oligomerization in response to activation of the chemical pathway of apoptosis. ML-1 cells were incubated with anisomycin and increasing concentrations of zinc. Total lysates of these cells were then obtained by digitonin lysis. Samples were crosslinked by glutaraldehyde and Western blot analysis was performed. No crosslinking of Bax was observed in the absence of an insult (Figure 3a) . Following incubation with anisomycin, Bax oligomerization was observed. We have previously shown that the size of the observed bands is consistent with homo-oligomerization. 10 Although 0.3 mM zinc inhibited cytochrome c release when given in combination with anisomycin, Bax oligomer formation was only partially reduced at this concentration of zinc. This inhibition is most obvious in the reduction of intensity of the high molecular weight bands, while at 3 mM zinc, oligomer formation was almost completely inhibited.
In ML-1 cells, Bak oligomer formation was also evident but was far less prominent than Bax oligomerization ( Figure 3 ). It is possible that Bak is only secondarily a player in ML-1 cells and this accounts for the low level of oligomerized Bak. However, the weak signal of Bak oligomerization was inhibited by 0.3 mM zinc. Bak oligomerization was much more evident in Jurkat cells that lack Bax (Figure 3b ). This oligomerization was substantially, but not completely, inhibited at 0.3 mM zinc. The fact that oligomerization of Bax and Bak was not completely inhibited at concentrations of zinc that completely prevented cytochrome c release is consistent with the idea that large molecular weight oligomers may be required for cytochrome c release. Hence, partial block of oligomer formation may be adequate to prevent cytochrome c release (see Discussion).
Zinc has multiple effects on the Fas pathway
We previously demonstrated that zinc can also prevent DNA digestion caused by receptor-mediated pathways of apoptosis.
14 ML-1 cells do not die rapidly upon incubation with antiFas antibody; therefore, the following experiments were performed in Jurkat cells. Cells were incubated for 5 h with 200 ng/ml anti-Fas antibody. Fas receptor activation caused DNA digestion as measured by agarose gel electrophoresis and D4GDI cleavage indicative of caspase 3 activation (Figure 4a ). In control cells, caspase 8 was found in the cytosolic fraction of cells (Figure 4b ). With the activation of the Fas receptor, caspase 8 was cleaved and found in both the cytosol and pellet fractions. Bid was found in the cytosol of control cells and anti-Fas antibody caused cleavage, and translocation to the pellet fraction. Cytochrome c was released into the cytosol by engagement of the Fas receptor just as in response to chemical-mediated apoptosis.
Increasing concentrations of zinc were coadministered with the anti-Fas antibody. Zinc (3 mM) inhibited DNA digestion and D4GDI cleavage (Figure 4a ). This was 10-fold higher than the concentration required to inhibit DNA digestion induced by anisomycin. Increasing concentrations of zinc inhibited the Mechanisms of zinc inhibition of apoptosis N Ganju and A Eastman appearance of the cleaved product of caspase 8 in the cytosol, but had no effect on the cleavage of caspase 8 in the pellet. However, the higher concentrations of zinc resulted in accumulation of the uncleaved parent form of caspase 8 in the pellet. This is consistent with the reported mechanism by which caspase 8 is recruited to the receptor where it is cleaved and eventually released back into the cytosol. These results suggest that zinc prevents the release of cleaved caspase 8 from the DISC.
Caspase 8 was clearly active in the pellet fraction as indicated by cleavage of Bid. Furthermore, zinc appeared to stabilize the cleaved form of Bid, which is frequently difficult to see because of secondary proteolysis. Only at the highest concentration of zinc was there a reduced level of Bid, yet this was similar in amount to that seen with anti-Fas antibody in the absence of zinc and is therefore likely to be sufficient to facilitate the release of cytochrome c.
Zinc does not inhibit Bak oligomerization that occurs during Fas-mediated apoptosis
Bid activation by anti-Fas results in Bak activation in the same fashion as Bax to facilitate cytochrome c release. 26 Figure 1 Zinc inhibits anisomycin-induced apoptosis in ML-1 cells. Cells were incubated with 10 mg/ml anisomycin and the indicated concentrations of zinc for 2 h. (a) DNA digestion was measured by agarose gel electrophoresis, and D4GDI cleavage was measured by Western blotting of total cell lysates. (b) Cell pellet and cytosol were separated by digitonin treatment, and the fractions were assayed by Western blotting for Bax, cytochrome c, caspase 8, and Bid lysates, followed by Western blot analysis ( Figure 5 ). Zinc at all concentrations used failed to prevent Bak oligomerization. This is consistent with the inability of zinc to inhibit cytochrome c release from the mitochondria in response to Fas. Together these results demonstrate that, in contrast to the chemicalinduced pathway, zinc inhibits the Fas-mediated apoptosis downstream of mitochondria; that is, after release of mitochondrial cytochrome c but before the proteolytic cleavage events mediated by downstream caspases.
Zinc inhibits apoptosis induced by TNF plus cycloheximide
In order to investigate the ability of zinc to inhibit receptormediated apoptosis in a cell line containing both Bak and Bax, ML-1 cells were treated with TNF and cycloheximide (CHX) in conjunction with increasing concentrations of zinc. TNF/CHX treatment alone resulted in caspase 8 cleavage and translocation of the cleaved product to the pellet fraction of cells. Bid was activated as visualized by the loss of the parent fraction of Bid in the cytosol although little of the cleaved fragment could be seen in the pellet. Bax translocated from the cytosol, cytochrome c was released from the mitochondria, D4GDI was cleaved and DNA digested ( Figure 6 ). When increasing concentrations of zinc were administered concurrently with TNF/CHX, 1-3 mM zinc appreciably inhibited DNA digestion and cleavage of the caspase 3 substrate D4GDI, which is similar to its efficacy in inhibiting Fas-induced apoptosis in Jurkat cells. cleaved fraction in the pellet, but it was still detectable in the cytosol fraction, and, furthermore, zinc did not inhibit the processing of caspase 8 from its parent form. Only partial inhibition of Bax translocation and cytochrome c release was achieved at 10 mM zinc. This result argues that Bid activation was not completely inhibited at 10 mM zinc as enough was still present to activate Bax and Bak and result in release of cytochrome c. Alternately, another undefined mechanism may be facilitating Bax and Bak activation. Bax and Bak oligomerized in response to TNF/CHX and little change was observed with zinc up to 10 mM (Figure 7) . Oligomerization, particularly in the case of Bax, generated a significant decrease in detectable antigenic epitope compared to the same samples that had not been subjected to crosslinking (note that this was also true in Figure 3 , but was not as prominent because there was a slightly lower level of overall crosslinking). This is particularly evident in the control lane in Figure 7 , suggesting that unoligomerized Bax is much more susceptible to glutaraldehyde-mediated alkylation of the antibody binding site. This is probably because of the different location of Bax in the cell: soluble in control cells or mitochondrial bound in apoptotic cells. Lighter exposures of the same blot show that the total levels of Bax or Bak did not change in response to addition of either the apoptotic insult or zinc (Figure 7) . In summary, these results are consistent with those obtained with anti-Fas in showing that zinc cannot prevent death-receptor-mediated Bax and Bak activation, but rather it inhibits apoptosis further downstream in the pathway.
Discussion
Zinc can inhibit apoptosis induced by both chemical and death-receptor agonists. Previous reports showed that zinc inhibits DNA digestion, caspase 3 activity, and caspase 3 activation. 16, 17, 23, 27, 28 None of these reports, nor many others on the subject, defined the exact step inhibited by zinc, but rather, they suggest the inhibited step(s) are further upstream in the apoptotic cascade. In the current study, we show that the protection afforded by zinc is dependent on both the concentration of zinc and the insult employed to induce apoptosis. The most significant observation made here is that zinc can inhibit Bax and Bak activation induced by a chemical insult but not by activation of death receptors. Hence, release of cytochrome c induced by anisomycin was inhibited by B0.3 mM, whereas it was not inhibited by zinc following incubation with either anti-Fas or TNF/CHX. In these deathreceptor pathways, apoptosis was still blocked by zinc, albeit at 3 mM, but this appeared to be because of inhibition of downstream caspase activity, probably because of loss of caspase activation as previously reported. 16 Recent reports have shown that either Bax or Bak activation is required to induce cytochrome c release in response to a chemical insult. 5, 6 This is consistent with our results showing that, in response to a chemical insult, ML-1 cells activate Bax and Bak, while Jurkat cells activate Bak in response to the same insult. This activation results in the release of cytochrome c from the mitochondria and continuation of the apoptotic cascade. Zinc was found to inhibit Bax and Bak oligomerization that normally occurs in response to anisomycin-induced apoptosis. Although there was a clear reduction in Bax and Bak oligomerization at 0.3-1 mM zinc that correlated with inhibition of cytochrome c release, complete inhibition of oligomerization was not observed until 10 mM. This finding is significant because it shows that Bax or Bak oligomerization occurs in response to an apoptotic stimulus in both pathways and that the inhibition of high molecular weight Bax or Bak oligomerization (i.e. greater than dimeric forms of Bax in Figure 3 ) correlates with the inhibition of cytochrome c release. It has been suggested that Bax produces oligomers containing up to 30 molecules that facilitate cytochrome c release; 29 hence, it may not be necessary to completely block oligomerization to prevent cytochrome c release. This would explain the appearance of low molecular weight oligomers of Bax or Bak, yet cytochrome c was not released from the mitochondria. 
(c) Bak oligomerization in Jurkat cells
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Following death-receptor activation, an approximately 10-fold higher concentration of zinc was required in order to inhibit D4GDI cleavage and DNA digestion than was required to inhibit the chemical-mediated death pathway. However, zinc failed to inhibit Bax/Bak activation or cytochrome c release at 3-10 mM zinc, demonstrating that zinc must be inhibiting apoptosis downstream of these events. The ability of zinc to inhibit cleavage of D4GDI is consistent with our previous report that zinc inhibited caspase 3 activation. 16 It is possible that zinc is mediating the inhibitory action at the level of the apoptosome that is required for caspase 9 activation. Alternately, in the case of a death-receptor pathway that bypasses the caspase 9 apoptosome, zinc might prevent the ability of Smac/ Diablo to activate caspase 3. 8, 9 This downstream inhibition of the caspase cascade probably also occurs in the chemical-induced pathways but is not seen because zinc Zinc also caused the accumulation of full-length caspase 8 and the cleaved form of Bid in the pellet fraction when administered in conjunction with anti-Fas. We surmise that zinc may be inhibiting a secondary proteolysis of these proteins. However, accumulation of these products was not seen in TNF/CHX-mediated apoptosis. It is possible that the presence of CHX in this model prevents the accumulation of these products.
Caspase 8 is recruited to the Fas receptor where it is activated. This recruitment results in cleavage and activation of Bid. Bid is a proapoptotic 'BH3-only' member of the Bcl-2 family. Other BH3-only proteins have been identified and the current model suggests that different BH3-only proteins are triggered by different insults and that they are required for Bax and Bak activation and subsequent release of cytochrome c. 30 In the case of engagement of the death receptors, Bid is thought to be the primary BH3-only protein assisting in the activation of Bax and Bak. The results presented here show that neither Bid cleavage nor Bax and Bak activation are inhibited by zinc in the death-receptor model. In contrast, in the case of anisomycin-mediated apoptosis, zinc does block Bax and Bak activation. This is consistent with previous data showing that Bid does not play a role in mediating Bax or Bak activation in response to apoptosis induced by a variety of chemical insults, 2, 10 and, furthemore, that Bid-deficient cells are not resistant to chemical insults. 31 Presumably, a different BH3-only protein is involved in mediating Bax and Bak activation in anisomycin-induced apoptosis. Several BH3-only proteins, such as Noxa and Puma, are transcriptionally regulated, primarily through p53. 30 Considering that anisomycin inhibits protein synthesis at the concentrations used, it is unlikely that these proteins are contributing to Bax or Bak activation in this context. Bad is regulated by phosphorylation, which leads to its sequestration on 14-3-3 proteins and away from mitochondria. Bim and Bmf are controlled by an alternate mechanism in which they are sequestered by either microtubules in the case of Bim or actin filaments in the case of Bmf. Release and translocation occurs upon receipt of an appro- In preliminary experiments, we have found that both Bad and Bim appear to be located primarily in the mitochondrial fraction, and in the case of Bim was completely separated from the fraction containing tubulin (data not shown). Hence, it is unlikely that Bim is sequestered by microtubules in these cell lines. One possibility is that Bim at the mitochondria is modified and/or changes conformation upon the induction of apoptosis much like Bak, and that this change allows it to bind and inhibit the antiapoptotic members of the Bcl-2 family. Alternately, Bad has recently been shown to be activated during apoptosis by phosphorylation on a novel residue, serine 128. 32 Zinc could therefore inhibit apoptosis by preventing these changes. In summary, we hypothesize that zinc mediates its protection in the anisomycin model by inhibiting a particular BH3-only protein. Zinc may be a valuable tool to help resolve which BH3-only proteins are required upon induction of apoptosis by various insults.
Materials and Methods
Materials
Cell culture medium was purchased from Mediatech, Inc. (Herndon, VA, USA). All other reagents including anisomycin, zinc sulfate, and digitonin were purchased from Sigma (St. Louis, MO, USA). Monoclonal antibody to Bax was obtained from Zymed Laboratories, Inc. (San Francisco, CA, USA). Polyclonal anti-Bid was a generous gift of Dr. Xiaodong Wang (HHMI, Dallas, TX, USA). Monoclonal anti-cytochrome c was purchased from Pharmingen (San Diego, CA, USA). Polyclonal anticaspase 8 was purchased from StressGen Biotechnologies Corp. (Victoria, BC, Canada ). D4GDI polyclonal antibody was raised in this laboratory. 33 Secondary goat anti-mouse and goat anti-rabbit antibodies conjugated with horseradish peroxidase were purchased from Bio-Rad (Hercules, CA, USA). Polyvinylidene fluoride (PVDF) membrane was from Millipore (Marlborough, MA, USA). ECL reagent was obtained from Amersham Pharmacia (Piscataway, NJ, USA). Figure 7 Bax and Bak oligomerization are induced by TNF plus cycloheximide but are not inhibited by zinc. ML-1 cells were incubated with TNF/CHX and the indicated concentrations of zinc for 5 h. Half of the total cell lysate was crosslinked with 0.3% glutaraldehyde. Crosslinked and noncrosslinked samples were then electrophoresed on the same gel and analyzed by Western blot. In the main panels, the film was over-exposed to visualize the crosslinked bands. In the case of Bak, many additional bands are observed at this exposure in the uncrosslinked lanes, but these disappear after crosslinking; the crosslinked band is slightly smaller than the major background band and is clearly visible only after crosslinking. The lower panels show a shorter exposure of the noncrosslinked samples to demonstrate no change in the total level of Bax or Bak
Cell culture
Jurkat T lymphocytes and ML-1 myeloid leukemia cells were maintained in 5% CO 2 at 371C in RPMI 1640 medium complete with 7.5% fetal bovine serum and 1% glutamine. All cultures were maintained in logarithmic growth at a density less than 10 6 cells/ml. Cells were incubated with 10 mg/ ml anisomycin for up to 2 h, 200 ng/ml anti-Fas antibody for up to 5 h, or 10 ng/ml TNF plus 5 mg/ml cycloheximide for 5 h to induce apoptosis. Indicated concentrations of zinc were added concurrently with apoptotic agents.
DNA fragmentation
DNA digestion was measured using agarose gel electrophoresis as described previously. 34, 35 Briefly, 10 6 cells were added directly to the wells of a 2% agarose gel, where they were lysed by SDS and digested with ribonuclease A and proteinase K. High molecular weight DNA remained trapped in the well, while DNA that had been digested during apoptosis migrated through the gel and was resolved into multiples of 180 base pair fragments. DNA was stained with ethidium bromide and visualized under ultraviolet light.
Immunoblotting
All samples were obtained by the digitonin permeabilization method. 36 Briefly, cells were permeabilized on ice with 8.75 mg digitonin/10 6 cells in 50 ml buffer containing 75 mM NaCl, 1 mM NaH 2 PO 4 , 8 mM Na 2 HPO 4 , 250 mM sucrose, and protease and phosphatase inhibitors. Cells were incubated for 30 s on ice-cold buffer followed by centrifugation for 1 min at 12 500 r.p.m. The supernatant was then removed as the cytosolic fraction and the pellet was resuspended in the same volume of buffer without digitonin. For total cell lysates, the same buffer was used but the fractions were not separated by centrifugation. Laemmli sample buffer (25 ml) supplemented with 10% b-mercaptoethanol was then added to all samples. Total and pellet fractions were solubilized by sonicating for 5 s at 41C and boiling for 5 min. Extracts were electrophoresed on 15% SDS/ polyacrylamide gels. Proteins were transferred to PVDF membrane, blocked for 1 h at room temperature in tris-buffered saline with 0.1% Tween 20 and 5% nonfat dairy milk. The membranes were then probed with specified antibody overnight at 41C. Secondary antibody was used at 1 : 3000 dilution and ECL was used to detect the signal.
Protein crosslinking
Cell cytosols and pellets were isolated using digitonin lysis as described above. Cells (2 Â 10 6 ) were harvested in 94 ml lysis buffer. A measure of 6 ml of 5% glutaraldehyde solution was added to the final concentration of 0.3% glutaraldehyde. Samples were then incubated for 30 min at room temperature. After the incubation period, reactions were quenched by the addition of 25 ml Laemmli sample buffer supplemented with 10% bmercaptoethanol. Samples were then boiled and electrophoresed on 12% SDS/polyacrylamide gels and analyzed as described above.
Chromatin condensation
Cells were incubated with 2 mg/ml Hoechst 33342 for 15 min at 371C. An aliquot of cells was transferred to a microscope slide, fitted with a coverslip, and DNA was visualized with a fluorescent microscope. Cells exhibiting condensed chromatin and fragmented nuclei were scored as apoptotic. At least 200 cells were scored from each sample, and data were expressed as the percentage of cells with condensed chromatin.
